Depression treatment is not one-size-fits-all. This guide compares evidence-based options—including psychotherapy, antidepressant medication, and combined care—so you can track progress, recognize side effects, and prepare focused questions for a qualified clinician.
Overview
Depression can affect mood, sleep, appetite, concentration, energy, relationships, and the ability to manage everyday responsibilities. Treatment decisions usually depend on symptom severity, duration, past treatment response, medical conditions, medications, personal preferences, access to care, and safety concerns.
The main evidence-based approaches are structured psychotherapy, medication, or a combination of both. Treatment may also include sleep and activity routines, care for coexisting medical or mental health conditions, and a plan to reduce the risk of relapse. Lifestyle steps can support recovery, but they should not be presented as a substitute for clinical care when depression is persistent, severe, or associated with safety concerns.
The comparison below is a starting point rather than a prescription. A primary care clinician, psychiatrist, psychologist, therapist, or other qualified professional can help determine which options fit the individual situation.
| Option | What it involves | Typical considerations |
|---|---|---|
| Psychotherapy | Regular sessions using structured approaches such as cognitive behavioral therapy, interpersonal therapy, or behavioral activation. | Requires time and active participation. Benefits may build over multiple sessions. Availability, cost, therapist fit, and format matter. |
| Antidepressant medication | Prescription medicine selected according to symptoms, health history, previous response, interactions, and preferences. | Side effects and safety monitoring are important. Improvement may begin gradually, and medication should not usually be stopped abruptly without medical advice. |
| Combined care | Psychotherapy and medication used together, sometimes with coordinated primary and specialty care. | May be considered when symptoms are more persistent or impairing, when one approach has not been enough, or when a person prefers both forms of support. |
What to track
A simple record can make treatment discussions more useful. Tracking does not need to become an all-day task. Once or twice a day, or at a consistent weekly interval, note the following:
- Core symptoms: mood, loss of interest or pleasure, hopelessness, guilt, irritability, anxiety, concentration, and motivation.
- Daily function: getting out of bed, attending work or school, personal care, eating, maintaining relationships, and completing essential tasks.
- Sleep and energy: bedtime, waking, total sleep, early waking, daytime fatigue, and unusual increases in energy or reduced need for sleep.
- Appetite and physical symptoms: changes in appetite, weight, agitation, slowed movement, pain, headaches, nausea, or other new symptoms.
- Treatment details: therapy dates, medication name and dose, missed doses, dose changes, supplements, alcohol or substance use, and other medicines.
- Possible side effects: nausea, diarrhea or constipation, sleep changes, sexual side effects, dizziness, emotional blunting, restlessness, or new agitation.
- Safety: thoughts of death, self-harm, suicide, feeling unable to stay safe, or concerning changes noticed by family or caregivers.
Antidepressants are commonly grouped into classes, including selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, atypical antidepressants, and older classes such as tricyclic antidepressants and monoamine oxidase inhibitors. They differ in interactions, contraindications, side-effect patterns, and monitoring needs. Do not compare medicines by class alone or change a dose based on a general article.
Therapy also varies. Cognitive behavioral therapy focuses on links among thoughts, feelings, and behavior. Behavioral activation emphasizes gradually rebuilding meaningful and rewarding activities. Interpersonal therapy addresses relationship changes, conflict, grief, and role transitions. The therapist’s training, the treatment structure, and the therapeutic relationship can be as relevant as the therapy label.
Cadence and checkpoints
Early follow-up is useful after starting, stopping, or changing treatment. The exact schedule depends on the treatment, age, medical history, severity, and safety risk. Ask the prescriber or therapist when the first review should occur rather than waiting indefinitely for improvement.
During the first days to weeks
Track new or worsening agitation, severe restlessness, marked sleep disruption, allergic symptoms, intolerable physical effects, or abrupt mood changes. Some medication side effects can appear before mood improves. Report concerning symptoms promptly. People at increased risk of self-harm may need a more detailed safety plan and closer contact.
After several weeks
Review both symptoms and function, not just whether you feel “better.” A useful checkpoint asks: Is mood changing? Is sleep more regular? Are daily tasks easier? Are side effects manageable? Has the person been able to attend therapy or take medication consistently? If there is little benefit, the clinician may reassess the diagnosis, treatment dose or duration, adherence barriers, coexisting conditions, substance use, bipolar-spectrum symptoms, and the need for a different or combined approach.
After improvement
Improvement is a reason to make a maintenance plan, not automatically a reason to stop treatment. Discuss how long to continue medication or therapy, how to recognize early warning signs, and what to do if symptoms return. Any medication reduction should be planned with the prescriber because abrupt changes can cause withdrawal-like symptoms or symptom recurrence.
How to interpret changes
Look for trends across two or more checkpoints rather than treating one difficult day as proof that treatment has failed. Progress may appear first as improved sleep, more regular eating, fewer missed responsibilities, or greater ability to use coping skills. Mood may improve more gradually.
A partial response is clinically meaningful information. It can guide a conversation about continuing, adjusting, switching, or adding treatment. Persistent symptoms do not mean that a person has failed; they may indicate that the working diagnosis, treatment fit, dose, therapy approach, medical contributors, or social circumstances need another review.
Also distinguish ordinary fluctuation from possible mania or hypomania. Periods of unusually elevated or irritable mood, markedly reduced need for sleep, racing thoughts, unusually rapid speech, impulsive decisions, or behavior that feels out of character should be reported promptly. These symptoms can affect treatment choices and warrant professional assessment.
Use a clinician-discussion template at each review:
- What symptoms have changed, and what has not changed?
- How is functioning different at home, work, school, or in relationships?
- What benefits and side effects have appeared?
- Are any medicines, supplements, alcohol, or substances affecting the plan?
- What is the next checkpoint, and what would trigger an earlier call?
- What is the relapse-prevention and safety plan?
When to revisit
Revisit this topic whenever depression treatment is being considered, started, changed, or evaluated. A practical schedule is to review symptoms and side effects at each clinical appointment, reassess the maintenance plan after meaningful improvement, and update the medication and safety list whenever another clinician prescribes a new treatment.
Seek urgent help for immediate danger, an inability to stay safe, a suicide attempt, severe confusion, psychosis, or rapidly escalating agitation. In the United States, call or text 988 for the Suicide & Crisis Lifeline; call emergency services or go to the nearest emergency department when there is immediate danger. In other countries, use the local emergency number or crisis service. If possible, do not stay alone during an acute safety crisis, and remove or secure items that could be used for self-harm.
For a routine appointment, bring the symptom log, current medication and supplement list, questions about expected timelines, and any observations from a trusted caregiver. Treatment guidance and safety warnings can change, so this article should be reviewed periodically—at least twice a year by publishers and sooner when major clinical guideline or regulatory updates occur. The goal is not to select a treatment from a table; it is to support a clear, ongoing conversation with a qualified clinician.
